ANTIHYPERTENSIVE THERAPY AND LIPIDS - EVIDENCE, MECHANISMS, AND IMPLICATIONS

[1] ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION [J]. AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) : 748 - 757

[2] AMES RP, 1982, J CARDIOVASC PHARM, V4, pS206

[3] METABOLIC DISTURBANCES INCREASING THE RISK OF CORONARY HEART-DISEASE DURING DIURETIC-BASED ANTIHYPERTENSIVE THERAPY - LIPID ALTERATIONS AND GLUCOSE-INTOLERANCE [J]. AMERICAN HEART JOURNAL, 1983, 106 (05) : 1207 - 1214

[4] [Anonymous], 1978, J Chronic Dis, V31, P201

[5] [Anonymous], 1979, JAMA, V242, P2562

[6] [Anonymous], 1982, JAMA, V248, P1465

[7] BRELMAN P, 1979, INT J CLIN PHARM THE, V17, P378

[8] BROWN MS, 1981, SCIENCE, V212, P623

[9] EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J]. AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) : 4 - 12

[10] METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6156) : 77 - 80

[1] ELEVATION OF SERUM-LIPID LEVELS DURING DIURETIC THERAPY OF HYPERTENSION [J]. AMERICAN JOURNAL OF MEDICINE, 1976, 61 (05) : 748 - 757

[2] AMES RP, 1982, J CARDIOVASC PHARM, V4, pS206

[3] METABOLIC DISTURBANCES INCREASING THE RISK OF CORONARY HEART-DISEASE DURING DIURETIC-BASED ANTIHYPERTENSIVE THERAPY - LIPID ALTERATIONS AND GLUCOSE-INTOLERANCE [J]. AMERICAN HEART JOURNAL, 1983, 106 (05) : 1207 - 1214

[4] [Anonymous], 1978, J Chronic Dis, V31, P201

[5] [Anonymous], 1979, JAMA, V242, P2562

[6] [Anonymous], 1982, JAMA, V248, P1465

[7] BRELMAN P, 1979, INT J CLIN PHARM THE, V17, P378

[8] BROWN MS, 1981, SCIENCE, V212, P623

[9] EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J]. AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) : 4 - 12

[10] METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J]. BRITISH MEDICAL JOURNAL, 1979, 1 (6156) : 77 - 80